Cargando…
The Real Role of β-Blockers in Daily Cardiovascular Therapy
The role of β-adrenoceptor antagonists (β-blockers) in cardiovascular therapy has been subject to diverse trends and changes over the decades. With the advent of a wide variety of excellent drugs for the treatment of antihypertension, β-blockers have been relegated from the first-line treatment of e...
Autores principales: | Dézsi, Csaba András, Szentes, Veronika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591796/ https://www.ncbi.nlm.nih.gov/pubmed/28357786 http://dx.doi.org/10.1007/s40256-017-0221-8 |
Ejemplares similares
-
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Prothrombotic Processes and Myocardial Infarction Risk
por: Dézsi, Csaba András, et al.
Publicado: (2016) -
Differences in the Clinical Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Critical Review of the Evidence
por: Dézsi, Csaba András
Publicado: (2014) -
Management of dental patients receiving antiplatelet therapy or chronic oral anticoagulation: A review of the latest evidence
por: Dézsi, Csaba András, et al.
Publicado: (2017) -
The Role of CXCR3 and Associated Chemokines in the Development of Atherosclerosis and During Myocardial Infarction
por: Szentes, Veronika, et al.
Publicado: (2018) -
The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?
por: Dézsi, Csaba András
Publicado: (2016)